Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00
Go back to Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00| US BioTec Inc New Common Shares (NASDAQ: SBC) | Delayed: 2.99 -0.03 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.02 | 52 Week High | $0.40 | |||
| Open | $2.95 | 52 Week Low | $0.40 | |||
| Day High | $3.05 | P/E | N/A | |||
| Day Low | $2.94 | EPS | $0.00 | |||
| Volume | 87,870 | |||||
